Athersys (ATHX) Director Jane Wasman Appointed Board Chair

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. ANT
3. META
4. SPY
5. FFAI
6. FFR
7. AZN
8. GMAB
9. CART
10. LLY

Go back to Athersys (ATHX) Director Jane Wasman Appointed Board Chair

Athersys Director Jane Wasman Appointed Board Chair

October 2, 2023 5:04 PM EDT

CLEVELAND--(BUSINESS WIRE)-- Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces changes to its Board of Directors following the Companys recent 2023 Annual Meeting of Stockholders. Current Director Jane Wasman, JD, has been appointed Board Chair, effective September 28, 2023. Ms. Wasman has served as a Director of the Company since November 2020, currently serving as Chair of Athersys Audit Committee and previously serving as Chair of its Nominations, Governance & Compliance Committee.

We are delighted that Jane will now be chairing Athersys board. She brings a wealth of expertise in... More